September 15, 2019
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
Read More
January 30, 2019
Case Management in HCV Infected PWID
Read More
January 30, 2019
Case Management in HCV Infected PWID
Read More
January 30, 2019
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3
Read More
January 30, 2019
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3
Read More
January 30, 2019
PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b
Read More
January 30, 2019
VX-950-C211 – A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
Read More
January 30, 2019
Effectiveness of Paritaprevir/Ritonavir – Ombitasvir, +/- Dasabuvir, +/- Ribavirin in Patients With Chronic Hepatitis C – An Observational Study in Belgium
Read More
January 30, 2019
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Read More
January 30, 2019
A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
Read More
January 30, 2019
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Read More
January 30, 2019
Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
Read More
Load More
X